Ikena Oncology (NASDAQ: IKNA) is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel, patient-directed, targeted therapeutics for cancer. Their pipeline focuses on biomarker-driven programs aimed at addressing unmet needs in various oncology indications. Ikena leverages its deep understanding of cancer biology and translational research to advance differentiated drug candidates designed to improve patient outcomes.
The headquarters serves as the central hub for Ikena's research and development, clinical operations, corporate strategy, and administrative functions.
Located in Boston's Seaport District, the facility includes modern laboratory and office spaces designed to foster collaboration and cutting-edge scientific research.
Ikena Oncology fosters a collaborative, innovative, and science-driven work environment. The culture emphasizes a strong commitment to patients, scientific rigor, and teamwork in the pursuit of breakthrough cancer therapies.
The Boston location provides Ikena with access to a rich ecosystem of leading academic institutions, research hospitals, talent, and potential collaborators in the biotechnology industry.
As a clinical-stage company, Ikena Oncology's global presence is primarily defined by its clinical trial activities, which may involve sites and collaborations across multiple countries to evaluate their therapeutic candidates. They also engage with regulatory authorities and research partners internationally.
645 Summer Street, Suite 101
Boston
MA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ikena Oncology' leadership includes:
Ikena Oncology has been backed by several prominent investors over the years, including:
Ikena Oncology announced key changes in its financial leadership over the past year, including the appointment of a new CFO and the transition of the former CFO.
Discover the tools Ikena Oncology uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ikena Oncology primarily uses the [first_initial][last_name]@ikenaoncology.com email format. Understanding this common pattern can be useful for professional outreach.
flast@ikenaoncology.com
Format
jdoe@ikenaoncology.com
Example
85%
Success rate
GlobeNewswire • May 9, 2024
Ikena Oncology announced its financial results for Q1 2024, highlighting progress in its clinical programs, including IK-930 targeting the Hippo pathway and IK-595, a MEK-RAF molecular glue. The company reiterated its focus on advancing its pipeline and upcoming data readouts....more
GlobeNewswire • April 2, 2024
Ikena presented promising preclinical data for IK-595, its novel MEK-RAF molecular glue, at the American Association for Cancer Research (AACR) Annual Meeting. The data demonstrated potent anti-tumor activity and differentiation from existing MEK inhibitors....more
GlobeNewswire • February 29, 2024
Ikena reported its Q4 and full-year 2023 financial results, outlining key achievements and upcoming milestones for its targeted oncology programs. The update included progress on patient enrollment for its IK-930 and IK-595 clinical trials....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ikena Oncology, are just a search away.